HR Execs on the Move

Implanet

www.implanet.com

 
Founded in 2007 and based near Bordeaux, IMPLANET is a medical technology company that manufactures high-quality implants for orthopedic surgery.
  • Number of Employees: 25-100
  • Annual Revenue: $10-50 Million
  • www.implanet.com
  • Inc. 60 State Street Suite 700
    Boston, MA USA 02109
  • Phone: N/A

Executives

Name Title Contact Details

Similar Companies

Minntech Corporation

Minntech Corporation is engaged in the development, manufacture and marketing of medical supplies and devices, sterilants and filtration and separation products. The Company's products are used primarily in kidney dialysis and in open-heart surgery. The

affordable home care agency ca

affordable home care agency ca is a Walnut Creek, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Episode Solutions

Episode Solutions provides resources and services, tailored exclusively to the needs of musculoskeletal physicians and physicians groups, to help evaluate and maximize physician performance in alternative payment structures, without sacrificing existing professional fee-for-service revenue. Episode Solutions provides the platform that enables MSK physicians to take advantage of the substantial opportunities to create and share in immediate savings through bundled payments.

Zeus Scientific, Inc.

Zeus Scientific, Inc. is one of the leading companies in the Healthcare, Pharmaceuticals, & Biotech sector.

Glaukos

Glaukos Corporation is an ophthalmic medical technology company focused on the development and commercialization of breakthrough products and procedures to transform the treatment of glaucoma, one of the world`s leading causes of blindness. Glaukos has pioneered Micro-Invasive Glaucoma Surgery, or MIGS, to revolutionize the traditional glaucoma treatment and management paradigm. The company launched the iStent Trabecular Micro-Bypass Stent, its first MIGS device, in the United States in 2012. Glaukos is leveraging its platform technology to build a comprehensive and proprietary portfolio of injectable micro-scale therapies designed to address the complete range of glaucoma disease states and progression. Glaukos believes the iStent is the smallest medical device ever approved by the Food and Drug Administration, or FDA, measuring 1.0 mm long and 0.33 mm wide. In June 2015, the company completed an initial public offering and its shares are now traded on the New York Stock Exchange under the ticker symbol "GKOS". Founded in 1998, Glaukos is based in San Clemente, California.